Roberta L. Beauchamp

Author

Massachusetts General Hospital

Also Known As

R Beauchamp, R L Beauchamp, Roberta Beauchamp, Roberta L Beauchamp, Roberta L. Beauchamp, Yo Niida

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Massachusetts Eye and Ear Infirmary Center for Human Genetics University of North Carolina at Chapel Hill

About

Roberta L. Beauchamp is an author at Massachusetts General Hospital specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.3K
2	Cell Biology	13	13	765
3	Social Sciences	2	2	79
4	Cellular Physiology	2	2	69
5	Engineering	1	1	30

Roberta L. Beauchamp

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Junya Toguchida, Toshikazu Yamaguchi, Bruce Ritchie, PubMed Gross RearrangementsSomatic VariantMalignant DiseaseTumor HeterogeneityP53 Gene	1992	302
p53 gene mutations and protein accumulation in human ovarian cancer. Jolanta Kupryjańczyk, Ann D. Thor, Roberta L. Beauchamp, Proceedings of the National Academy of Sciences OncologyTumor HeterogeneityP53 GeneP53 Protein AccumulationP53 Gene Mutations	1993	299
Analysis of bothTSC1 andTSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis Yo Niida, Nicole Lawrence-Smith, Ashleigh Banwell, Human Mutation Tuberous Sclerosis ComplexMendelian DisorderGenetic DisorderMedicineGenetics	1999	153
Universal absence of merlin, but not other ERM family members, in schwannomas. Anat Stemmer‐Rachamimov, Lin Xu, Charo Gonzalez-Agosti, PubMed	1997	125
The merlin tumor suppressor localizes preferentially in membrane ruffles. Charo Gonzalez-Agosti, Lin Xu, Denise Pinney, PubMed	1996	114
Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas. Liang‐Guo Xu, Dennis C. Sgroi, Christopher J. Sterner, PubMed Tumor BiologyBreast OncologyMutational AnalysisMedicineCdkn2 Gene	1994	109
Regulation of mTOR Complex 2 Signaling in Neurofibromatosis 2–Deficient Target Cell Types Marianne F. James, Elizabeth Stivison, Roberta L. Beauchamp, Molecular Cancer Research	2012	105
Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease. Jolanta Kupryjańczyk, Ann D. Thor, Roberta L. Beauchamp, PubMed	1996	84
Pam and Its Ortholog Highwire Interact with and May Negatively Regulate the TSC1·TSC2 Complex Vanishree Murthy, Sangyeul Han, Roberta L. Beauchamp, Journal of Biological Chemistry	2004	80
Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma Fabio P. Nunes, Yiping Shen, Yo Niida, Cancer Genetics and Cytogenetics Inactivation PatternsSystems BiologyMedicineCell BiologyCell Signaling	2005	72

Page 1